Australia's Telix Pharmaceuticals has announced the official opening of Telix Manufacturing Solutions (TMS) in Yoko...
Teijin Limited and BioVaram, the brand name of the UR Advanced Therapeutics Pvt Ltd. (URAT), si...
Japan-headquartered Nxera Pharma has announced a focused restructuring designed to concentrate investment and resources ...
As Japan transitions into a super-aged society, the demand for long-term care and assistive technologies is growing rapi...
US-based BostonGene, developer of the leading AI foundation model for cancer and the immune system, and Kyoto ...
Japan's Kaneka Corporation has begun sales of its i-ED COIL™, a brain aneurysm embolisation coil, in Europe as of ...
NEXT Oncology, an Avacare business, has expanded its services to Asia through a strategic partnership with Kansai Medica...
Fujifilm Corporation has signed a joint research agreement with the National Cancer Center Japan, a Tokyo-based national...
4D Molecular Therapeutics has announced a strategic partnership with Otsuka Pharmaceutical to develop and commercialise ...
With the CDMO segment seeing rapid growth, how would you describe the changing profile of your clients, and how is Teiji...
German firm Boehringer Ingelheim has licensed a pre-clinical programme from Japan's Kyowa Kirin to develop a potential f...
Japan-based Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately JPY 1.73 b...
MEDINET Japan and Stempeutics India (a group Company of Manipal Education & Medical Group) have signed an option lic...
Japan-based Renalys Pharma and Chugai Pharmaceutical have announced a definitive stock purchase agreement, under which C...
Japan-based medtech company Olympus Corporation has announced the launch of THUNDERBEAT™ II, the next generation h...
France-based Naobios, a CDMO providing bioprocess development and GMP production of clinical batches of virus-based prod...
China's Innovent Biologics has announced a strategic global collaboration with Japanese pharmaceutical firm Takeda to ad...
Japan's Chugai Pharmaceutical and US-based Rani Therapeutics, LLC, a subsidiary of Rani Therapeutics Holdings, Inc., hav...
